Table 1 Clinical characteristics of patients with early-stage gastric cancer
From: Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer
Characteristics | n (%) |
|---|---|
Total | 157 (100) |
Age | |
≥ 60y | 91 (58.0) |
< 60y | 66 (42.0) |
Sex | |
Male | 116 (73.9) |
Female | 41 (26.1) |
Tumor location | |
Cardia | 33 (21.0) |
Corpus | 58 (37.0) |
Antrum | 66 (42.0) |
Differentiation | |
Poor | 99 (63.1) |
Well | 58 (36.9) |
Tumor invasion | |
T1 | 18 (11.5) |
T2 | 20 (12.7) |
T3 | 73 (46.5) |
T4 | 46 (29.3) |
Lymph node | |
N0 | 41 (26.1) |
N + | 116 (73.9) |
TNM stage | |
I | 27 (17.2) |
II | 43 (27.4) |
III | 87 (55.4) |
HER-2 expression | |
Negative | 79 (50.3) |
Low | 50 (31.8) |
Positive | 13 (8.3) |
Unknown | 15 (9.6) |